Pay-for-Delay’ Drug Case Moves Forward – New York Times
The European Commission told Lundbeck, a Danish drug company, that it thought the company’s agreements with generic companies violated antitrust laws by preventing the entry, for as long as two years, of competing generic versions of citalopram.
Subscribe to LegalLaw247.Com Newsletter
